TP53 and prostate cancer: For example, computational analysis has identified potential binding sites for HIF-1a and NF-κB in CXCR2 promoter in hypoxic prostate cancer cells [28] and p53 reportedly upregulates CXCR2 transcription by binding to CXCR2 promoter [29].